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Extramedullary plasmacytomas are plasma cell neoplasms in organs other than the bone marrow. Most are found in the upper
respiratory tract. Involvement of the pancreas is rare. We report a case of pancreatic plasmacytoma in association with advanced
multiple myeloma.
1.Case
A 66-year-old African American woman ﬁrst presented with
left hip pain. MRI showed a left iliac wing tumor which was
determined to be a plasmacytoma on subsequent CT-guided
biopsy. She developed progressive disease over the next
four years including lesions in multiple ribs and vertebral
bodies, pelvis, skull, humeri, and femurs. She was treated
with dexamethasone, thalidomide, and numerous courses of
radiation, all with variable response.
The Patient was subsequently found to have elevated
transaminases. On PET/CT, in addition to multiple bony
lesions, there was an intensely FDG avid upper abdominal
mass. The mass was in the region of the head and body of the
pancreas with no deﬁnite pancreatic duct dilation (Figure 1).
Biopsy conﬁrmed multiple myeloma (Figure 2). The patient
was admitted to the hospital two months later for jaundice
with an elevated direct bilirubin due to the pancreatic mass
compressing the distal common bile duct (Figure 3). She
underwentatherapeuticERCPwithdistalcommonbileduct
stent placement which caused her jaundice to resolve. She
then completed a second course of radiation and chemother-
apy. Follow-up CT of the abdomen and pelvis showed
signiﬁcant reduction in the size of the pancreatic mass.
Findings remained stable on subsequent studies until
two years later when the patient developed nausea and
abdominal pain. CT demonstrated interval enlargement
of the pancreatic head mass. The patient received addi-
tionalpalliativeradiationtherapy;howeverfollow-upstudies
showed multiple new metastatic liver lesions as well as an
inﬁltrative mass in the porta hepatis encasing the portal vein,
common hepatic artery and gastroduodenal artery (Figure
4). The porta hepatis mass appeared to extend from the
pancreatic head mass. Since conventional therapy was no
longer working, the patient was admitted into a clinical trial
and expired four months later.
2. Discussion
Five percent of all plasma cell neoplasms involve organs
outside the bone marrow [1]. These tumors are called
extramedullary plasmacytomas. They are usually diagnosed
after multiple myeloma of the bone marrow. Although the
majorityofextramedullaryplasmacytomasinvolvetheupper
respiratory tract, ten percent occur in the gastrointestinal
tract, primarily the liver, spleen, or stomach [2, 3].
There are approximately 25 case reports of pancreatic
involvement in the English language literature. While they
candevelopinanypartofthepancreas,manyoftheselesions
arelocatedinthepancreatichead.Diﬀuseenlargementofthe
pancreas has also been reported [3, 4]. Patients will typically
present with abdominal pain and obstructive jaundice from
compressionof thecommonbileduct[5].OnCT,pancreatic
plasmacytoma is commonly characterized as a homoge-
neously enhancing solid mass [6]. While this appearance
is unlike that of a pancreatic adenocarcinoma, it can be
diﬃcult to distinguish from hypervascular neuroendocrine
tumors. Percutaneous or open biopsy as well as endoscopic
ultrasound-guided ﬁne needle aspiration can be helpful in2 Case Reports in Radiology
Figure 1: Axial PET/CT fusion image demonstrates a large, inten-
sely FDG avid mass in the region of the pancreas (green arrow).
Figure 2: Core biopsy of the abdominal mass demonstrating sheets
of atypical plasma cells which were positive with monoclonal kappa
light chain staining by immunoperoxidases stains. No staining was
seen for lambda light chains. (H&E stain, 20x magniﬁcation).
Figure 3: Contrast-enhanced axial CT image demonstrates a large
homogeneously enhancing mass in the region of the pancreatic
head which is causing compression of the distal common bile duct
(red arrow).
Figure 4: Contrast-enhanced coronal CT image demonstrates an
ill-deﬁned mass in the porta hepatis causing compression of the
portal vein and common bile duct (red arrow).
ruling out the other diﬀerential possibilities for a pancreatic
mass including serous and mucinous tumors [7, 8].
Plasma cell tumors tend to be very radiosensitive and
chemosensitive, so the treatment of choice for extramedul-
lary plasmacytomas is generally some combination of sur-
gery,chemotherapyandradiationtherapy[9,10].ERCPwith
stenting of the biliary system is often performed for symp-
tomatic relief of obstructive jaundice. Thalidomide and stem
cell transplants are also currently under investigation [4].
One should always consider extramedullary plasmacytoma
when a multiple myeloma patient presents with a mass.
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